Research programme: Therapeutic DNA Vaccines
Latest Information Update: 24 May 2024
At a glance
- Originator Immuno Cure
- Class Antineoplastics; Cancer vaccines; DNA vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cervical cancer; Colorectal cancer; Lung cancer; Ovarian cancer
Most Recent Events
- 26 Apr 2024 Preclinical trials in Cervical cancer in China (IM) (Immuno Cure pipeline, April 2024)
- 26 Apr 2024 Preclinical trials in Colorectal cancer in China (IM) (Immuno Cure pipeline, April 2024)
- 26 Apr 2024 Preclinical trials in Lung cancer in China (IM) (Immuno Cure pipeline, April 2024)